Novel serial positive enrichment technology enables clinical multiparameter cell sorting

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Stemberger, Christian ^a,b   Dreher, Stefan ^a,b   Tschulik, Claudia ^c   Piossek, Christine ^c   Bet, Jeannette ^a,b   Yamamoto, Tori N ^f   Schiemann, Matthias ^a,d   Neuenhahn, Michael ^a,g   Martin, Klaus ^b   Schlapschy, Martin ^b   Skerra, Arne ^b   Schmidt, Thomas ^c   Edinger, Matthias ^e   Riddell, Stanley R ^b,f   Germeroth, Lothar ^c   Busch, Dirk H ^a,b,d,g  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Stage Cell Therapeutics   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^f Fred Hutchinson Cancer Research Center   (United States)

^g DZIF National Centre for Infection Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45RA ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; CD45 ANTIGEN; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL LABELING; CELL SEPARATION; CONTROLLED STUDY; ENRICHMENT CULTURE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MALE; MEMORY T LYMPHOCYTE; PURIFICATION; REGULATORY T LYMPHOCYTE; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; METHODOLOGY; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, CD8; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; L-SELECTIN; MALE; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 84860169849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035798     Document Type: Article

References (31)

1. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, et al. (1992) Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238-241.
2. Cobbold M, Khan N, Pourgheysari B, Tauro S, McDonald D, et al. (2005) Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 202: 379-386.
3. Schmitt A, Tonn T, Busch DH, Grigoleit GU, Einsele H, et al. (2011) Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion 51: 591-599.
4. Rooney CM, Smith CA, Ng CY, Loftin S, Li C, et al. (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345: 9-13.
5. Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, et al. (1996) Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 2: 551-555.
6. Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME, (2008) Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8: 299-308.
7. Stemberger C, Huster KM, Koffler M, Anderl F, Schiemann M, et al. (2007) A Single Naive CD8(+) T Cell Precursor Can Develop into Diverse Effector and Memory Subsets. Immunity 27: 985-997.
8. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, et al. (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9: 1144-1150.
9. Taylor PA, Lees CJ, Blazar BR, (2002) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99: 3493-3499.
10. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL, (2002) CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 196: 401-406.
11. Riley JL, June CH, Blazar BR, (2009) Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 30: 656-665.
12. Randolph DA, Fathman CG, (2006) Cd4+Cd25+ regulatory T cells and their therapeutic potential. Annu Rev Med 57: 381-402.
13. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, et al. (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
14. Hoffmann P, Eder R, Boeld TJ, Doser K, Piseshka B, et al. (2006) Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 108: 4260-4267.
15. Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, et al. (2008) Adoptive transfer of effector CD8 T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest 118: 294-305.
16. Turtle CJ, Riddell SR, (2011) Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy. Curr Opin Immunol 23: 299-305.
17. Yang S, Gattinoni L, Liu F, Ji Y, Yu Z, et al. (2011) In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells. Cancer Immunol Immunother 60: 739-749.
18. Knabel M, Franz TJ, Schiemann M, Wulf A, Villmow B, et al. (2002) Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat Med 8: 631-637.
19. Kohm AP, McMahon JS, Podojil JR, Begolka WS, DeGutes M, et al. (2006) Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol 176: 3301-3305.
20. Bes C, Briant-Longuet L, Cerutti M, Heitz F, Troadec S, et al. (2003) Mapping the paratope of anti-CD4 recombinant Fab 13B8.2 by combining parallel peptide synthesis and site-directed mutagenesis. J Biol Chem 278: 14265-14273.
21. Orlandi R, Gussow DH, Jones PT, Winter G, (1989) Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci U S A 86: 3833-3837.
22. Schiweck W, Skerra A, (1997) The rational construction of an antibody against cystatin: lessons from the crystal structure of an artificial Fab fragment. J Mol Biol 268: 934-951.
23. Skerra A, (1994) A general vector, pASK84, for cloning, bacterial production, and single-step purification of antibody Fab fragments. Gene 141: 79-84.
24. Schlapschy M, Gruber H, Gresch O, Schafer C, Renner C, et al. (2004) Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach. Protein Eng Des Sel 17: 847-860.
25. Fiedler M, Skerra A, (1999) Use of thiophilic adsorption chromatography for the one-step purification of a bacterially produced antibody F(ab) fragment without the need for an affinity tag. Protein Expr Purif 17: 421-427.
26. Schmidt TG, Skerra A, (2007) The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins. Nat Protoc 2: 1528-1535.
27. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
28. Nadali G, de Wynter EA, Testa NG, (1995) CD34 cell separation: from basic research to clinical applications. Int J Clin Lab Res 25: 121-127.
29. Attarwala H, (2010) TGN1412: From Discovery to Disaster. J Young Pharm 2: 332-336.
30. Chatenoud L, (2003) CD3-specific antibody-induced active tolerance: from bench to bedside. Nat Rev Immunol 3: 123-132.
31. Kjer-Nielsen L, Dunstone MA, Kostenko L, Ely LK, Beddoe T, et al. (2004) Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3. Proc Natl Acad Sci U S A 101: 7675-7680.